Covid may no longer be the most “significant” threat to health, Dr Jenny Harries has said.
The chief executive of the UK Health Security Agency said today that Covid was possibly no more dangerous than flu, as she warned that there would be a lower immunity to the illness this year.
She said: “It is important to remember that for an average flu season it’s about 11,000 deaths a year, it’s somewhere between four (thousand) to 22,000 over the last four to five years.
The authorities are literally going against the science and lying to victims of Covid in order to avoid creating a benefit that others might seek out at a potential risk. Except that they themselves are responsible for creating the restrictive system from which people are now literally seeking out infection to find relief – if only to acquire a health pass good for six months so they’re able to access everyday venues and basic freedoms.
Peter McCullough, MD, MPH speaks at the 78th Annual Meeting of AAPS on October 2, 2021.
- 1min: Something was going very wrong very early in 2019.
- 2m: The threshold for shutting down a new biologic product is just a few cases.
- 3m: Covid-19 was going to be the showcase of what we could do for biotech.
- 5m: The spike protein created by the new Covid-19 is a deadly protein.
- 11m: Our institutions are all culpable in medical malfeasance.
- 13m: We have the biggest biological catastrophe on our hands with a medicinal product in human history…and no-one knows how to stop it.
- List of risk
- 14m: 86% of deaths have no other explanation other than the vaccines.
- 20m: We are in freefall into a lawless state. The Vaccines are not safe for use on either side of the Atlantic. It’s clear that this first generation of [Covid-19] vaccines is not safe.
- 22m: The FDA did not approve Pfizer. The gave a continuation of the emergency use authorization and then conditionally approved Comirnaty with BioNTech which is legally and potentially medicinally distinct. The Pfizer approval is a false talking point.
- 23m: When Pfizer came up for boosters, McCullough and his team presented at the FDA showing that death with the vaccine is greater than death just taking your chances with the infection. The vaccines aren’t safe across the board and the panel agreed 16:2 against the booster.
- 26m: Data for the efficacy of the vaccines do not take into account the Delta variant. These vaccines have failed against Delta and other variants. Two-thirds who get sick with Delta are fully vaccinated. Data shows that the vaccines can’t stop transmission.
- 27m: Effectiveness for Pfizer is at 42%. A vaccine that falls below 50% protection and can’t last a year is not a viable product. Pfizer has failed as a commercial product.
- 29m: The CDC was telling us in May 2021 that the vaccines were failing. They started to do asymmetric reporting to craft a narrative that this was going to be a crisis of the unvaccinated but the CDC data showed the opposite. The ineptitude and willful misconduct of the people running our public health agencies is astounding.
- 32m: The ‘99% of hospitalized were unvaccinated’ message was a propagandized false talking point because the data is not there.
- 33m: The vaccines have had zero impact on the epidemic curve. Mortality is a function of treatment.
- 34m: Many experts have been warning that we shouldn’t vaccinate into a pandemic because it creates resistance. As soon as we started vaccinating, the number of strains starting falling. The virus was figuring out how to thrive in the vaccinated.
- 36m: The Delta variant has achieved antigenic escape. The data shows that the vaccinated is an equal threat to the unvaccinated.
- 38m: Early home treatment is the only thing that makes sense. That’s what it should have always been.
- 40m: Doctors at my institution cannot look me in the eye because they are so ashamed of what they’ve done during the course of this pandemic.
- 44m: If you look through the clinical records [of those who have died] and I will tell you they were all inadequately treated.
- 50m: Natural immunity is superior to vaccine immunity. If we vaccinate people who are covid-recovered, we harm them considerably. The only backstop is natural immunity.
Dr. Philip McMillan interviews vaccine developer Geert Vanden Bossche and Robert Malone MD, inventor of mRNA vaccine platform.
- Geert Vanden Bossche (GV) at 17m: Massive surges of the infection rates, especially in countries with an aggressive mass-vaccination policy, was predictable.
- Robert Malone (RM) at 23m: The Israeli data is a concern: we are seeing signs that the durability of the [Pfizer vaccine] is very poor.
- RM at 26m: The vaccinated are a higher risk of becoming superspreaders because they’re replicating virus at the same or higher levels than the unvaccinated but they feel better.
- GV at 28m: The effect of mass-vaccination is an ideal breeding-ground for more infections spread. However, if still have a substantial proportion that is non-vaccinated, you will see a reduction of infectious pressure.
- GV at 31m: The unvaccinated are ‘the vaccum cleaners’ who will eliminate a lot of virus from the population by mounting long-lived immunity and contribute to the reduction of infectious pressure. The vaccinated cannot contribute to the infectious pressure.
- RM at 33m: The truth is that it’s the vaccinated that are creating the risk, not the unvaccinated. The unvaccinated are serving as virus sinks. The probability of them having significant disease and death is minute. The real risk is the vaccinated who have received very focused spike proteins.
- GV at 35m: It is not a problem of individuals being vaccinated. The problem is a policy of mass-vaccination. That is how the more infections variant can adapt to the population and become dominant.
- GV at 58m: Young people are now getting the disease pretty fast because of the increased infectious pressure [due to mass-vaccination].
- RM at 1h10m: There are disincentives to asking questions about data for vaccine-enhanced replication and antibody-dependent enhancement; no-one wants fund the studies.
- GV at 1h12m: Regulators have no experience with the current situation where there are very many unknowns when deploying a new vaccine to the public.
- RM at 1h17m: The FDA is not structured to detect adverse advents and have admitted they cannot evaluate safety. Two of the top [US] regulators resigned because the FDA is no longer independent from the policy-making apparatus which exists in the Executive Branch [of US Government].
- RM at 1h24m: There is an intrinsic conflict of interest in the CDC in that it is funded to promote vaccines but also has the under-funded mission of evaluating their safety.
- RM at 1h25m: Policy recommendations together with Peter Navarro (American economist and author):
- Reserve vaccines for the high-risk population and make it available globally.
- Make early interventions [like Ivermectin and Vitamin D] widely available. Many are very effective when administered early and aggressively.
- Make home-test kits available (acknowledging that they have a bias to false positives) and make more specific tests in physicians offices.
- Address the fear by showing that currently most people are not at risk.
- GV at 1h30m: The most important thing is to reduce the infectious pressure. This is a huge threat to all those who were naturally protected, such as young people. The worst thing to do is to vaccinate the younger age groups because they are ‘the buffer’ of long-lived immunity. They are our hope for herd immunity. We will not get herd immunity from mass-vaccination.
- GV at 1h39m: We need to compare the ratio of severe disease of deaths in vaccinated and unvaccinated. We are seeing more case fatalities in the vaccinated but the numbers are not being made available.
- RM at 1h41m: There is a persistent signal in the UK data that there seems to be an excess deaths in the vaccinated and yet a relative deficit in the vaccinated. This is paradoxical.
- GV at 1h47m: Discrimination against the non-vaccinated is complete scientific nonsense. We should care about susceptibility. What is relevant is how can we protect ourselves best.
While focus remains firmly fixed on Covid-19, a second health crisis is quietly emerging in Britain. Since the beginning of July, there have been thousands of excess deaths which were not caused by coronavirus.
According to health experts, this is highly unusual for the summer. Although excess deaths are expected during the winter months, when cold weather and seasonal infections combine to place pressure on the NHS, summer generally sees a lull.
According to the Office for National Statistics (ONS) since July 2, there have been 9,619 excess deaths in England and Wales, of which 48 per cent (4,635) were not caused by Covid-19.
Professor Sucharit Bhakdi: “You are now witnessing the greatest crime that England has ever committed in its history.”
Professor Sunetra Gupta of Oxford University explains herd immunity, highlighting critical details about both the concept and its relevance to the COVID-19 pandemic that are often overlooked in public discussion.
The development of immunity through natural infection is a common feature of many pathogens, and we now know that COVID-19 does not have any tricks up its sleeve to prevent this from happening. If it did, it would have posed a serious problem for the development of a vaccine.
That being said, COVID-19 belongs to a family of viruses that do not typically confer lifelong immunity against infection. Most of us have never heard of the other four ‘seasonal’ coronaviruses that are currently circulating in our communities. And yet, surveys indicate that at least 3% of the population is infected by any one of these corona cousins during the winter months each year. These viruses can – and do – cause deaths in high-risk groups or require them to receive ICU care or ventilator support. Hence, it is not necessarily true that they are intrinsically milder than the novel COVID-19 virus. And like the COVID-19 virus, the other coronas are much less virulent in the healthy elderly and younger people than influenza.
One important reason why these corona cousins do not kill large numbers of people is that, even though we lose immunity and can be reinfected, there is always a sufficient proportion of immune people within the population to keep the risk of infection low for those who might die upon contracting it. Also, all of the coronaviruses in circulation — including COVID-19 — have some features in common, which means that getting one coronavirus will probably offer some protection against the others. This is becoming increasingly clear from work in many labs, including my lab in Oxford. It is against the background of acquired immunity to COVID-19 itself, as well as its close relations, that the new virus has to operate.
It is misleading to speak of “reaching” herd immunity. Herd immunity is a continuous variable that increases as people become immune and decreases as they lose immunity or die. There is a threshold of herd immunity at which the rate of new infections begins to decrease. We do not yet have a clear idea of what this threshold is for COVID-19 as the transmission landscape includes people who are susceptible to it, people who have built up immunity to it, and people who have immunity to other coronaviruses.
Unfortunately, we do not have a good way of telling how many people have been exposed to the new virus, nor how many people were resistant to begin with. We can test for antibodies but, as with other coronaviruses, COVID-19 antibody levels decline after recovery, and some people do not make them at all. Thus, antibody levels will not answer this question. More and more evidence is accumulating that other arms of immunity, like T cells, play an important role.
Indications of the herd immunity threshold having been reached in a given location are visible in the time signatures of epidemics where death and infection curves tend to either “bend” in the absence of intervention or to stay down when interventions are relaxed (in comparison with other locations where the opposite happened). Unfortunately, we do not know how far (or close) we are to that threshold in most parts of the world. This means that we need to make public health decisions based only on limited information and do so in a constantly changing environment.
Focused Protection was initially proposed as a solution for how we could proceed in the face of such uncertainty and it remains relevant now. It suggests that we exploit the fact that COVID-19 does not cause much harm to the large majority of the population and allow those individuals to resume their normal lives, while shielding those who are vulnerable to severe disease and death. We have good information about who falls into these groups and the availability of vaccines, which offer excellent protection for vulnerable populations and guard against hospitalisable illness, provide us with the ideal setting in which to implement such a plan.
Sunetra Gupta is Professor of Theoretical Epidemiology in the Department of Zoology, University of Oxford and a member of Collateral Global’s Scientific Advisory Board.
By Professor Sunetra Gupta
28 May 2021
This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.
I reiterate our call: “slow down and get the science right—there is no legitimate reason to hurry to grant a license to a coronavirus vaccine.”
FDA should be demanding that the companies complete the two year follow-up, as originally planned (even without a placebo group, much can still be learned about safety). They should demand adequate, controlled studies using patient outcomes in the now substantial population of people who have recovered from covid. And regulators should bolster public trust by helping ensure that everyone can access the underlying data.
“We could be digging ourselves into a hole, for a very long time, where we think we can only keep Covid away by boosting every year,” Prof Eleanor Riley, an immunologist from the University of Edinburgh, told me.
Prof Adam Finn, a government vaccine adviser, said over-vaccinating people, when other parts of the world had none, was “a bit insane, it’s not just inequitable, it’s stupid”.
Epidemiologist and public health professor Michael Baker used the metaphor of forest brushfires: if a year or two have passed without fire, there is more fuel on the ground to feed the flames. When a fire finally comes, it burns much more fiercely. “What we’re seeing now is we’ve accumulated a whole lot of susceptible children that have missed out on exposure – so now they’re seeing it for the first time,” Baker said.
…“The lack of immune stimulation… induced an “immunity debt” which could have negative consequences when the pandemic is under control and [public health intervientions] are lifted,” the doctors wrote. “The longer these periods of ‘viral or bacterial low-exposure’ are, the greater the likelihood of future epidemics.”
Some good news and some troubling news, from Professor Sucharit Bhakdi, M.D.
Oracle Films recently produced an interview with Professor Sucharit Bhakdi in collaboration with Oval Media in Germany, for an upcoming documentary.
As an aside to the interview, Dr. Bhakdi emphasised the urgent need to share the following information that has emerged from new scientific literature.
PLEASE take the time to process this presentation. Dr. Bhakdi explains clearly, based on new scientific evidence, why he believes:
* Your immune system is your best defence against SARS-CoV-2, and indeed all coronaviruses. If you have been infected, even if you experienced no symptoms at all, you are immune to all variants.
* We have already reached herd immunity.
* There is no scientific reason to vaccinate against SARS-CoV-2. There is simply no benefit and the rollout must be stopped.
Update: On 17 July 2021, Dr. Geert Vanden Bossche posted a response to Dr. Bhakdi’s conclusions. Both agree that mass vaccination should halt but differ on the dangers of variants and whether herd immunity has been reached.
Common colds may prime the immune system against Covid, scientists believe, after finding that some people never develop an infection despite repeated exposure to the virus.
Researchers at University College London (UCL) have discovered that some people have natural protection against Covid and seem to fight off an infection using pre-existing memory T-cells.
One of the UK’s leading childhood health experts has said there is not enough evidence to support vaccinating children against Covid, and the body that will make the decision on whether to jab under-18s has indicated it will take a cautious approach.
Prof Calum Semple, a member of the Scientific Advisory Group for Emergencies (Sage), said there was “rock-solid data” to show that the risk of severe harm to children from Covid was “incredibly low”.
We report broad serological profiles within the cohort, detecting antibody binding to other human coronaviruses. 202(>99%) participants had SARS-CoV-2 specific antibodies, with SARS-CoV-2 neutralization and spike-ACE2 receptor interaction blocking observed in 193(95%) individuals. A significant positive correlation (r=0.7804) between spike-ACE2 blocking antibody titers and neutralization potency was observed. Further, SARS-CoV-2 specific CD8+ T-cell responses were clear and quantifiable in 95 of 106(90%) HLA-A2+ individuals.
Professor Robert Dingwall said children may be “better protected by natural immunity generated through infection than by asking them to take the ‘possible’ risk of a vaccine”.
…On Wednesday, Prof Dingwall, a social scientist who sits on a subcommittee of the Scientific Advisory Group for Emergencies (Sage) as well as on the JCVI, spoke out, saying the “risk/benefit for teenagers must be firmly established” before any decisions were taken.
In a detailed Twitter thread, he said: “Teenagers are at intrinsically low risk from Covid. Vaccines must be exceptionally safe to beat this. Given the low risk of Covid for most teenagers, it is not immoral to think that they may be better protected by natural immunity generated through infection than by asking them to take the possible risk of a vaccine.”
SARS-CoV-2 spike antigen-specific IgG and IgA elicited by infection mediate viral neutralization and are likely an important component of natural immunity, however, limited information exists on vaccine induced responses. We measured COVID-19 mRNA vaccine induced IgG and IgA in serum serially, up to 145 days post vaccination in 4 subjects. Spike antigen-specific IgG levels rose exponentially and plateaued 21 days after the initial vaccine dose. After the second vaccine dose IgG levels increased further, reaching a maximum approximately 7–10 days later, and remained elevated (average of 58% peak levels) during the additional >100 day follow up period. COVID-19 mRNA vaccination elicited spike antigen-specific IgA with similar kinetics of induction and time to peak levels, but more rapid decline in serum levels following both the 1st and 2nd vaccine doses (<18% peak levels within 100 days of the 2nd shot). The data demonstrate COVID-19 mRNA vaccines effectively induce spike antigen specific IgG and IgA and highlight marked differences in their persistence in serum.
Scientists from the Cleveland Clinic, USA, have recently evaluated the effectiveness of coronavirus disease 2019 COVID-19) vaccination among individuals with or without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The study findings reveal that individuals with previous SARS-CoV-2 infection do not get additional benefits from vaccination, indicating that COVID-19 vaccines should be prioritized to individuals without prior infection. The study is currently available on the medRxiv* preprint server.
Conclusions Individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination, and vaccines can be safely prioritized to those who have not been infected before.
SARS-Cov-2 is a more stable virus than influenza. Trillions of replications have thrown up a handful of variants of concern, clustering around a small set of mutations. These variants are worth monitoring but the vaccines effectively prevent them causing serious illness. There is a theoretical risk of a more dangerous variant but it does not seem more likely than a shift in the influenza virus. If it were to occur, we could now manage it with short-term measures and rapid vaccine modification.
…Vaccination protects the vaccinated. It helps protect others but it means that we take no greater risk in the autumn of 2020 than in the autumn of 2019. Interventions should be proportionate to that – which means that most cannot be justified.
Some are worth retaining, like improved hygiene in public places or greater readiness to stay at home with respiratory symptoms. It is probably a good idea to invest further in the search for effective antiviral therapies. Promoting better population health through diet and exercise is always a good thing. But it is time for a bonfire of face masks and the despatch of lateral flow tests to landfill.